4
Changes in Ownership
Cartesian Therapeutics, Inc. Filed Acc 0001453687-25-000112
Options or other derivatives
- Chief Accounting Officer acquired 50,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Seymour June Ann Chief Accounting Officer | 2025-10-27 | Grant or award · Employee Stock Option (right to buy) | +50,000 | 50,000 | D: show line 1 in the form |
Loading xslF345X05/wk-form4_1761681948.xml…